In the evaluation of exercise intolerance of patients with respiratory diseases the American Medical Association (AMA) and the American Thoracic Society (ATS) have proposed similar classifications for rating aerobic impairment using maximum oxygen uptake (VO 2 max) normalized for total body weight (ml min -1 kg -1 ). However, subjects with the same VO 2 max weight-corrected values may have considerably different losses of aerobic performance (VO 2 max expressed as % predicted). We have proposed a new, specific method for rating loss of aerobic capacity (VO 2 max, % predicted) and we have compared the two classifications in a prospective study involving 75 silicotic claimants. Logistic regression analysis showed that the disagreement between rating systems (higher dysfunction by the AMA/ATS classification) was associated with age >50 years (P<0.005) and overweight (P = 0.04). Interestingly, clinical (dyspnea score) and spirometric (FEV 1 ) normality were only associated with the VO 2 max, % predicted, normal values (P<0.01); therefore, in older and obese subjects the AMA/ATS classification tended to overestimate the aerobic dysfunction. We conclude that in the evaluation of aerobic impairment in patients with respiratory diseases, the loss of aerobic capacity (VO 2 max, % predicted) should be used instead of the traditional method (remaining aerobic ability, VO 2 max, in ml min -1 kg -1 ). 
Introduction
Relating the loss of pulmonary function to the degree of exercise intolerance (impairment) (1,2) remains a controversial aspect of occupational medicine (1, 6) . Complaints of dyspnea in patients with occupation-related pulmonary disorders often exceed objective findings, especially in claimants, and it is well recognized that accurate assessment of work capacity must consider that subjects may be limited by non-respiratory problems (7) . Analysis of metabolic and ventilatory responses during exercise has significantly improved the quality of both occupational and non-occupational respiratory disease evaluation (8) . The American Thoracic Society (ATS; 1,2) and the American Medical Association (AMA; 3-5) have proposed similar criteria for rating remaining aerobic ability, based on maximum oxygen uptake (VO 2 max) attained in the laboratory. The observed values are normalized by actual weight (ml min -1 kg -1 ) allowing comparisons with the estimated work metabolic stress. For example, if an individuals VO 2 max is found to be greater than 25 ml min -1 kg -1 , remaining aerobic ability is judged normal using this scheme (Table 1) .
Nevertheless, patients with identical measured VO 2 max (expressed as l/min) may demonstrate marked differences between remaining ability (VO 2 max, ml min -1 kg -1 ) and loss of capacity (VO 2 max, % predicted). A younger, non-obese individual with a high predicted normal VO 2 max may have sustained a considerable loss of capacity and yet have a normal remaining capacity (VO 2 max >25 ml min -1 kg -1 ). On the other hand, an older and especially overweight individual may have an abnormally low VO 2 max expressed ml min -1 kg -1 even though the loss of aerobic capacity expressed as VO 2 max, % predicted, may be slight. Therefore, rating aerobic dysfunction using only remaining ability (VO 2 max, ml min -1 kg -1 ) could lead to major discrepancies when compared to a scheme expressing loss of capacity (VO 2 max, % predicted).
The aim of the present study was to compare conclusions reached by two systems of rating aerobic dysfunction based on VO 2 max measured in a heterogeneous group of silicotic claimants: 1) a system similar to the AMA/ATS classification (1-5) (VO 2 max, ml min -1 kg -1 ) and 2) a new system based on reduction of VO 2 max values compared to predicted (VO 2 max, % predicted; Table 1 ). We hypothesized that there would be significant differences between the two systems that could lead to potentially different conclusions about impairment in individual subjects.
Material and Methods

Subjects and clinical evaluation
A group of subjects undergoing evaluation was available for comparison of aerobic performance. These claimants with occupational exposure to free silica in the ceramics industry generally had some degree of dyspnea, and had radiographic abnormalities suggestive of silicosis. No patient was excluded due to a co-morbidity factor if the latter was compensated (systemic arterial hypertension, diabetes mellitus). Any medications utilized by the patients were maintained. Informed consent to participate in the study was obtained from all subjects. The protocol was submitted to and approved by the Ethics Committee of UNIFESP/EPM-HSP.
Clinical, occupational and smoking histories were obtained; physical examination and anthropometric evaluation were performed in all subjects. A dyspnea score was recorded using a Cotes modified scale (9) in which a normal degree of respiratory effort was defined as breathlessness occurring while walking uphill or climbing stairs, but not with a lesser degree of exertion. Posteroanterior chest radiographs were interpreted by two experienced readers according to the International Labor Organization (10) classification of radiographs of pneumoconiosis.
Spirometry
Pulmonary function tests were performed 
Cardiopulmonary exercise testing
The exercise study was performed with the subject sitting on a calibrated, electromagnetically braked cycle ergometer (CPE-2000, MGC). The cycle seat was adjusted for the subjects comfort. The cycle ergometer was interfaced with a digital computerbased exercise system (CPX-System, MGC) which increased the work rate at a constant rate (ramp protocol). The increase in work rate (10 to 20 watts/min) was chosen in such a way that the symptom-limited maximum was obtained between 8 and 12 min. Subjects breathed through a 115-ml deadspace, low-resistance Hans-Rudolph valve. The expiratory arm of the valve was connected to a Fleisch-type No. 3 pneumotachograph and the flow signal was electronically integrated to obtain volume variables. A 1-ml/s sample of expired gas from the mouthpiece was drawn for determination of expired O 2 and CO 2 with a zirconium cell and rapid infrared analyzer, respectively. Gas measurements and flow were analyzed breath-by-breath after phase delay correction (13) . All subjects had their heart rate measured and electrocardiogram obtained each minute; subjects were also monitored by pulse oximetry (OxyShuttle TM SensorMedics, SensorMedics Corp., Anaheim, CA).
The exercise test consisted of measurements of gas exchange and flow at rest for 2 min, 2 min while the subject was pedaling without a load, and then while the work rate was increased until the subject indicated that he could not continue pedaling at least at 50 rpm, or the test was stopped by the attending physician. All subjects were encouraged to perform as long as possible. At the end of exercise, the subject was asked to describe his symptoms and to rate the severity of dyspnea, fatigue and leg pain (modified Borg scale; 14). Exercise could be terminated by the physician if a subject had a fall in systolic blood pressure (BP) of more than 15 mmHg, systolic BP >250 mmHg, diastolic BP >120 mmHg, progressive horizontal or downsloping ST-segment depression, T-wave inversion or the appearance of Q waves, increased frequency of premature ventricular contraction, ventricular tachycardia (3 or more consecutive ectopic beats), onset of atrial fibrillation or atrial tachycardia (15), or pulse oximeter oxyhemoglobin saturation (SaO 2 ) <80%.
The following variables were measured during the test: breath-by-breath O 2 uptake (VO 2 , ml/min, standard temperature and pressure, dry; STPD), CO 2 output (VCO 2 , ml/ min STPD), respiratory exchange ratio (R), minute ventilation (VE, l/min, body temperature, ambient pressure, saturated BTPS), breathing frequency (f, bpm), tidal volume (VT, ml/min BTPS), ventilatory equivalents for O 2 and CO 2 (VE/VO 2 , VE/VCO 2 ), endtidal PO 2 and PCO 2 (PETO 2 , PETCO 2 , mmHg), dead space/tidal volume ratio (VD/ VT), heart rate (HR, b/min) and oxygen pulse (VO 2 /HR, ml/beat).
The VO 2 achieved by the subjects at maximal effort, limited by symptoms or by medical reasons, was considered to be the VO 2 max (peak VO 2 ), and was defined as the highest value obtained in the analysis of 8-breath moving average. VO 2 max was expressed as % predicted according to the reference values of Hansen and coworkers (16) : i) in eutrophic and underweight males, the predicted VO 2 max (ml/min) was calculated us-ing the actual weight: weight (kg) x 50.72 -0.372 x age (years) and, ii) in overweight subjects, the ideal weight normalized for height was used: VO 2 max = (0.79 x height (cm) -60.7 x 50.72 -0.372 x age (years).
The anaerobic threshold (VO 2 AT) was estimated by gas exchange at the point at which VCO 2 increased out of proportion to VO 2 (V-slope) and when the VE/VO 2 ratio and the PETO 2 increased while the ratio VE/ VCO 2 and PETCO 2 remained constant (13). The lower limit of normality for VO 2 AT was set at 40% of predicted VO 2 max (13). The reading was performed by two observers who always agreed in their analysis. The predicted maximal HR (HRmax) was calculated as 220 -age (13) . The chronotropic reserve was calculated by the equation: 1 -HRmax/HRpred, and the breathing reserve using the standard equation 1 -VEmax/MVV.
Statistical analysis
The Kappa reliability test was used to determine the presence of significant concordance between the classifications of aerobic dysfunction. Logistic regression analysis was performed to correlate the demographic and anthropometric variables with the discordance between the classifications. The Mann-Whitney U-test was carried out to contrast excess weight values among groups. To evaluate the associations among some studied variables, we used chi-square analysis (Fishers exact test). For all tests, a P value <0.05 was considered to be statistically significant.
Receiver operating characteristic (ROC) analysis was used to choose an appropriate VO 2 max % predicted cutoff value for comparison to the VO 2 max ml min -1 kg -1 criterion and to test the relative accuracy of the two systems (17) . A ROC plot consists of a statistical method designed to evaluate the overall relationship between sensitivity and specificity of a test against a selected gold standard. Assuming a necessary inverse relationship between sensitivity and specificity, the best decision threshold corresponds to the best possible combination of sensitivity and specificity and, therefore, the area under the curve is closely related to the overall accuracy of the test. In this experiment, the selected gold standard was the VO 2 AT, a variable that provides a global assessment of aerobic performance independent of effort or of achieving a true VO 2 max (13). Thus, a ROC plot was constructed by plotting the true-positive fraction (sensitivity) against the false-positive fraction (1-specificity) for multiple VO 2 max decision thresholds using discrete test values (17). 
Results
Seventy-five subjects (67 males and 8 females) participated. Mean age was 52.2 years and many subjects had a history of smoking. Fifty-eight subjects (55 males and 3 females) were classified as having small opacities and 17 (12 males and 5 females) as having large opacities by roentgenographic analysis (10) . Clinical, spirometric and exercise findings are presented in Table 2 .
In the new classification, the lower limit of normality (70% of predicted VO 2 max) was the best possible combination between sensitivity and specificity changing the VO 2 max % predicted values against the gold standard (VO 2 AT). Thus, the point closest to the upper left corner of Figure 1 was selected as the best cutoff for normality for the new method.
In a global comparison between the two schemes, we found that of 75 studied subjects, only 19 (25.3%) were classified as normal by the AMA/ATS criteria (VO 2 max >25 ml min -1 kg -1 ). On the other hand, 40 of 75 subjects (53.3%) had a VO 2 max >70% predicted (no loss of aerobic capacity), including 21 of 56 subjects with VO 2 max <25 ml min -1 kg -1 . No subject with VO 2 max >25 ml min -1 kg -1 had a VO 2 max <70% predicted (Table 3) .
We anticipated that age might have an impact on the different schemes due to the generally lower predicted VO 2 max in older subjects (above 50 years). As shown in Table  3 , there was a significant difference regarding the gradation of aerobic dysfunction just in the older group (k = 0.03, P = 0.29). Among patients older than 50 years (group II), of 22 patients with VO 2 max >70% predicted, only 5 (22.7%) had normal remaining aerobic ability. Furthermore, only 4 of these older subjects were considered to have severe functional loss (VO 2 max <40% predicted), compared to 17 classified as severe on the basis of VO 2 max <15 ml min -1 kg -1 . Therefore, in patients >50 years old, VO 2 max expressed as ml min -1 kg -1 frequently suggested a lower remaining ability compared to the milder degree of loss of capacity found by looking at VO 2 max % predicted. In summary, the interpretation of the two VO 2 max analyses was concordant for 61% of subjects younger than 50 years as opposed to only 23% of 44 older subjects (Table 3) .
We also hypothesized that overweight individuals would be more likely to show a difference between the two schemes. Those subjects who showed concordance for VO 2 max (normal or abnormal for both meth- 
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VO2max (% predicted) VO 2 max (ml min -1 kg -1 ) Figure 1 -Receiver operating characteristics (ROC) curves of the two classifications, using the VO 2 at the anaerobic threshold (VO 2AT) as the gold standard for aerobic dysfunction. Open squares, Cutoffs of normality for VO 2max regarding to the two classifications; AUC = area under the ROC curve. ods of analysis) were as a group closer to normal body weight than those who were discordant, and this was true for both younger and older subjects ( Figure 2 ). Using a logistic regression analysis that considered disagreement between the classifications as dependent event and demographic and anthropometric variables as independent variables, only age and actual weight contributed to explaining the discordance (age, P = 0.0006; actual weight, P = 0.04; sex, P =0.15; height, P = 0.84).
We also compared the normality suggested by the two classifications with that indicated by a clinical (dyspnea score) and respiratory function (FEV 1 above lower 95% confidence limit) indicator. In older subjects (group II), a significant association was found between the absence of functional loss (VO 2 max >70% predicted) and a dyspnea score <1 and a normal FEV 1 . A similar relationship between these variables and VO 2 max (ml min -1 kg -1 ) was not found (Figure 3) .
Finally, a direct comparison between ROC curves and the areas under the curves demonstrated a better performance of the new proposal (VO 2 max, % predicted) compared to current recommendations (VO 2 max, ml min -1 kg -1 ) (Figure 1 ). In addition, contrasting the lower limits of normality according to the two classifications showed a significant gain in specificity using the 70% value of VO 2 max predicted. Thus, while sensitivity remained unaltered, the new proposal allowed an improvement in specificity from 32.6% to 70% with a likelihood ratio increasing from 1.26 to 4.06 ( Figure 1 ).
Discussion
In this comparative study of two ways of expressing aerobic dysfunction (VO 2 max, ml min -1 kg -1 , and VO 2 max, % predicted) in a group of silicotic claimants, we found important disagreement in classifying normal subjects and in estimating the degree of abnormality. In particular, for subjects older than 50 years and for overweight subjects (actual weight above the ideal weight for height), using VO 2 max (ml min -1 kg -1 ) would frequently lead to the conclusion of a greater aerobic dysfunction than when using the VO 2 max % predicted expression. Our findings suggest that the present recommendations for rating aerobic dysfunction in pulmonary patients could cause considerable misinterpretation about the presence and degree of impairment.
Work-related respiratory limitation of exercise has long been quantified in classifications of aerobic dysfunction, usually by correcting the VO 2 max values for body weight (1) (2) (3) (4) (5) 18, 19 New classification AMA/ATS Figure 3 -Percentage of subjects with normal VO 2 max expressed as ml min -1 kg -1 or VO 2 max as % predicted for subjects older than 50 years who had a normal dyspnea score (<1) or normal FEV 1 (above lower 95% confidence interval). *P = 0.01; **P<0.00001 (Fishers exact test).
ability is appropriate for job placement or fitness-for-duty evaluations, but ignores the potential physiological importance of loss of aerobic capacity.
Our results indicated that recommendations based on VO 2 max (ml min -1 kg -1 ) can be significantly different from a classification based on loss of aerobic capacity ( Table  3 ). The disagreement between the classifications is particularly noticeable in older and heavier individuals. Thus, in those older than 50 years, with low absolute VO 2 max values (l/min), the actual weight correction in overweight individuals led to lower remaining ability than functional loss. In these patients, the loss of aerobic capacity was proportionally small in view of their low predicted values. These findings are particularly important considering that this demographic and anthropometric profile is the most prevalent in claimants with respiratory diseases (20) . VO 2 max normalization for actual weight -1 , a common procedure in sports medicine, should be justifiable only in activities where the total dynamic displacement of the body is the rule (fast walking, running) (21) and not the exception, as in most industrial plants and extractive sites (22) . In activities without active body movement, such as short distance walking, cycling and weight lifting, the normalization of actual weight for height (ideal weight) would prevent the overestimation of the predicted values of VO 2 max in overweight subjects (16) .
The lower limit of normality established by the new proposal (70% of predicted VO 2 max) was a best decision threshold obtained from a ROC curve constructed with VO 2 AT as the criterion for aerobic dysfunction (Figure 1 ). VO 2 AT is defined as the level of exercise VO 2 above which oxidative-based energy production is overlapped by anaerobic mechanisms. Typically, this is associated with increases in blood lactate, ventilatory and cardiac responses, catecholamine release, and a reduction of endurance time (13) . Furthermore, the effort-independent characteristic of this parameter is especially interesting for the aerobic evaluation of claimants (23) . The intermediate impairment cutoffs follow those usually recommended for pulmonary function tests (11) . The limit of severe aerobic impairment was established at 40% of predicted VO 2 max considering that it is the lower limit of normality for VO 2 AT (16). Thus, if a claimant shows a VO 2 max below this value, obviously his VO 2 AT will be very low and he is likely to utilize predominantly unsustainable anaerobic sources of energy in his activities.
Usually, the validation of a classification of aerobic dysfunction for occupational purposes is done in comparison with ergonomic assumptions. In order to use a less controversial criterion, we compared the normality detected by the two tested schemes with a clinical score of dyspnea (9) , and a measure of ventilatory limitation at rest (FEV 1 ) (11). The significantly stronger association between normality detected by the new proposal (VO 2 max >70% predicted) and that suggested by such parameters (Figure 3 ) indicated that a large number of patients over 50 years and overweight were incorrectly considered impaired on the basis of the present recommendations.
The utilization of VO 2 AT as a gold standard of aerobic dysfunction in a ROC analysis permitted a comparison of the two classifications along the entire spectrum of possible decision thresholds. The visual inspection of the curves and the direct comparison between the cutoff points of normality suggested by the two classifications showed a significant gain in specificity in the new proposal with the sensitivity of the AMA/ ATS scheme being maintained. When we analyzed the points on the ROC curves above 60% sensitivity and specificity we observed a striking superiority of VO 2 max expressed as % of predicted values (Figure 1 ). These findings are consistent with the tendency of excessive false-positive rates for aerobic ab-normality obtained when using the AMA/ ATS classification (ml min -1 kg -1 ).
In conclusion, our data indicate that in the assessment of aerobic dysfunction in pulmonary patients, loss of aerobic capacity expressed as VO 2 max % predicted should be an important parameter to be considered in the evaluation of potential impairment. Thus, instead of the comparison with the metabolic requirements of the work (remaining aerobic ability, VO 2 max in ml min -1 kg -1 or l/ min), loss of capacity should be considered to optimize the maximum VO 2 analysis. However, additional research is necessary to evaluate whether or not these findings are also applicable to normal aged overweight subjects.
